So am I. However, dynamics are very different with the EMA acceptance currently. Given history and the last move to $30 on basically nothing, I expect ADXS to revisit that number range b4 EMA approval, simply because it has in the past AND short interest has declined significantly.
The only thing stopping a trend up and move to $30 is bad news on trials, results, the hold, and things of the like.
I'm very optimistic and confident that the pps will be in double-digits sooner than we realize.